Active — Not RecruitingNot Applicable

Prevalence of OSA and Diagnostic Accuracy of Type 3 Home Sleep Test in Difficult-to-treat Asthma

Thailand37 participantsStarted 2024-02-07

Plain-language summary

cross sectional cohort study enroll Patients diagnosed with difficult-to-treat asthma, aged over 18 years, and experiencing persistent symptoms as assessed by the Asthma Control Test (ACT) underwent type 1 in-laboratory polysomnography and type 3 HSAT within 1 month apart

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * difficult-to-treat asthma . * Patients aged 18 years or older Exclusion Criteria: * Patients or volunteers unable to undergo type 1 and type 3 sleep studies, * Patients with symptoms compatible with other sleep disorders, * Patients with a history of or current stroke or transient ischemic attack and Other chronic respiratory diseases. * Patients diagnosed with obstructive sleep apnea

What they're measuring

prevalence of OSA in patients with difficult-to-treat asthma

Timeframe: up to 4 months

Trial details

NCT IDNCT06916858

SponsorChulalongkorn University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-06-30

View on ClinicalTrials.gov More OSA trials